Bladder Cancer
Trimodality Therapy: A Growing Consideration in the Treatment of MIBC
State-of-the-Art Lecture
Learning objectives
As a result of attending this session, participants will be able to:
- Describe the rationale and patient selection for trimodality therapy for muscle invasive bladder cancer (MIBC).
- Discuss optimal systemic therapies for trimodality therapy
- Report contemporary cancer and treatment outcomes
- Roger Buckley, Masoom Haider, Eric Hyndman
- Stephen Pautler
EF1: Advances in Prostate Biopsy: Improving Yield and Minimizing Harm
Educational Forum
Learning objectives
As a result of attending this session, participants will be able to:
- Describe the use of MRI and MRI fusion biopsies in the diagnosis of prostate cancer
- Review microultrasound approaches to prostate biopsy and compare with other modalities
- Discuss the safety and effectiveness of transperineal prostate biopsy
- Ricardo Rendon
ADT Adverse Events and Management Strategies
Guidelines
Learning objectives
As a result of attending this session, participants will be able to:
- Discuss the most common side effects of ADT
- Gain insight into the recommendation for prevention of complications from use of ADT
- Review ways to engage PCPs in the management of patients receiving ADT
Prostate Cancer
The Role of Surgery in High Risk Prostate Cancer
State-of-the-Art Lecture
Learning objectives
As a result of attending this session, participants will be able to:
- Define high-risk prostate cancer
- Understand the limitations to the available data surrounding surgery and radiation therapy in high risk prostate cancer
- Identify the need for investigating imaging, genomics and therapies for high risk prostate cancer.
Speakers
Noah Stern, Western University | The impact of ethnicity on prostate cancer mortality in Canada |
Jethro Kwong, University of Toronto | End-to-end deployment of an explainable machine learning model to predict risk of side-specific extraprostatic extension in men with prostate cancer |
Thomas Southall, Memorial University of Newfoundland | Magnetic resonance imaging – ultrasound fusion targeted prostate biopsies: Finding prostate cancer in patients with previously negative biopsies and elevated PSA |
Fred Saad, Centre Hospitalier de l’Université de Montréal | Molecular determinants associated with long-term response to apalutamide (APA) in nonmetastatic castration-resistant prostate cancer (nmCRPC) |
Narhari Timilshina, University of Toronto | Quality of care during active surveillance in low risk prostate cancer patients: A population-based approach |
Nawar Touma, McGill University | Type of androgen deprivation therapy and the risk of cardiovascular diseases in patients with prostate cancer with or without pre-existing cardiovascular risk |
- Moderator: Anil Kapoor
Prostate Cancer
Podium & Rapid Fire Abstracts
Learning objectives
As a result of attending this session, participants will be able to:
- Explore risk modelling for prostate cancer including: active surveillance, EPE and mortality.
- Discuss medical management including ADT and apalutamide.
- Explore MRI Fusion biopsy and the role in clinical practice
Male Infertility
Restorative Therapies for Erectile Dysfunction
State-of-the-Art Lecture
Learning objectives
As a result of attending this session, participants will be able to:
- Understand where restorative therapies fit in the erectile dysfunction treatment algorithm
- Discuss the differences between Gainswave shockwave & Low intensity shockwave therapy as well as PRP & Stromal vascular fraction for ED
- Evaluate the mechanisms at play for shockwave and PRP
- Trustin Domes, Matt Roberts, Rhonda St. Croix, Susan Moffatt-Bruce
- Keith Rourke
EF2: Maintaining Professional Competency in the COVID-19 Era
Educational Forum
Learning objectives
As a result of attending this session, participants will be able to:
- Explain the potential impact of COVID-19 on acquisition of knowledge and technical skills
- Describe changes to medical education at all levels as a result of COVID-19
- Integrate some strategies for continuous professional development into the “new normal”
- Ethan Grober
Testosterone Deficiency
Guideline
Learning objectives
As a result of attending this session, participants will be able to:
- Review the risk factors and health implications of testosterone deficiency.
- Summarize the diagnostic approach and treatment strategies for testosterone deficiency.
- Review and update the historical controversies surrounding testosterone therapy.
Legal
Virtual Consultations during COVID: Medico-Legal Considerations
State-of-the-Art Lecture
Learning objectives
As a result of attending this session, participants will be able to:
- Explain the concept of “reasonable care”
- Identify three privacy considerations related to providing virtual care
- Explain two considerations in managing wait times when resuming in-person care
- 21:45 - 22:15 ET
Speakers
Curtis Nickel, Queen’s University | Sublingual vaccination with MV140 prevents recurrent urinary tract infections in women: Preliminary results from a randomized, double-blind, placebo-controlled trial |
Jeannette Johnstone, Queen’s University | Influence of the COVID-19 pandemic on the burnout rates of graduating Canadian urology residents |
Bonnie Liu, Western University | Prospective evaluation of postoperative pain and opioid use after minor urologic surgery |
MayLynn Ding, McMaster University | Survey of Canadian urology residency programs: Perception of virtual education during the COVID19 pandemic and beyond |
David Mikhail, Lenox Hill Hospital, Manhattan, NY | Development and National implementation of virtual urology electives during COVID-19 pandemic |
Travis LeBlanc, University of Alberta | The impact of COVID-19 on urology resident surgical experience: An analysis of national case logs |
- Moderator: Premal Patel
Infections and Beyond
Podium & Rapid Fire Abstracts
Learning objectives
As a result of attending this session, participants will be able to:
- Understanding the implications of COVID-19 on Canadian urology residency education
- Understanding the potential role of MV140 vaccination in preventing recurrent urinary tract infections
- Understanding postoperative opiod use after minor urologic surgery
BPH
Is HoLEP the New Gold Standard for BPH Procedures?
State-of-the-Art Lecture
Learning objectives
As a result of attending this session, participants will be able to:
- Identify the potential complications of HoLEP including retrograde ejaculation, incontinence and retreatment rates
- Identify the criteria for HoLEP to be performed as an outpatient procedure without an indwelling catheter
- Identify the benefits of HoLEP compared to TURP with regards to objective voiding parameters and short and long term follow up
- Mélanie Aubé-Peterkin, Blair Egerdie, Dean Elterman, Amy Krambeck
- Naeem Bhojani
EF3: The Evolution of BPH Surgical Management: Outpatient Treatment of Large Volume Prostate Glands
Educational Forum
Learning objectives
As a result of attending this session, participants will be able to:
- Appreciate the advantages of BPH outpatient treatment
- Compare the different surgical options available for BPH outpatient treatment
- Understand the limits of various surgical options available for BPH outpatient treatment
- Jason Lee
Ureteral Calculi
Guideline
Learning objectives
Participants will understand the evidence-based recommendations for:
- The conservative management of ureteral calculi
- Indications, optimization and comparative analysis of SWL vs ureteroscopy with laser lithotripsy for ureteral calculi
- The management of ureteral calculi in special clinical situations (eg pregnancy, paediatrics)
Stones
Optimizing Surgical Stone Outcomes: Reducing Residual Fragments
State-of-the-Art Lecture
Learning objectives
As a result of attending this session, participants will be able to:
- Understand the true stone free rate of current surgical stone procedures
- Be familiar with the outcomes of residual stone fragments
- Be aware of measures to improve stone free rates
- 21:45 - 22:15 ET
Speakers
Jeannette Johnstone, Queen’s University | The association of new onset diabetes and medical therapy for benign prostatic hyperplasia |
Dean Elternman, University Health Network Toronto | Large, multi-center, prospective registry of Rezūm water vapor therapy benign prostatic enlargement |
Michael Ordon, University of Toronto | Incidence and treatment trends for kidney stones in Canada: A population-based cohort study |
Ahmed Ibrahim, McGill University Health Center | GreenLight laser prostatectomy: Are outcomes sustainable after a decade of surgery? A single-center experience with up to 15 years’ follow-up |
Runhan Ren, University of Alberta | Antibiotic use and microbial resistance patterns in patients with ureteric stents |
Vardhil Gandhi, University of Alberta | Analgesic use after endourologic surgery: A provincial analysis of 13,000 patients |
- Moderator: Monica Farcas
Prize Essay Competition Winner: Jeannette Johnstone, Queen's Urology POD-3
Endourology
Podium & Rapid Fire Abstracts
Learning objectives
As a result of attending this session, participants will be able to:
- Understand the potential benefits of Greenlight laser therapy and Rezūm water vapor therapy for BPH
- Have better knowledge of the incidence and treatment trends of kidney stones in Canada
- Have a better understanding of analgesic use after endoscopic surgery and antibiotic use in stented patients
Upper Tract
Upper tract TCC: Systemic Therapy Strategy
State-of-the-Art Lecture
Learning objectives
As a result of attending this session, participants will be able to:
- Consider the evidence for adjuvant and neoadjuvant treatment in UTUC
- Discuss the findings from the POUT trial
- Implement into daily practice
- Adrian Fairey, Girish Kulkarni, Ross Mason
- Peter Black
EF4: Management of High Risk NMIBC
Educational Forum
Learning objectives
As a result of attending this session, participants will be able to:
- Appreciate the advantages of BPH outpatient treatment
- Stratify risk in patients with non-muscle invasive bladder cancer in order to select patients for immediate cystectomy.
- Optimize first line therapy for patients with high risk non-muscle invasive bladder cancer.
- Understand the clinical trials landscape and newly approved agents for BCG-unresponsive high risk non-muscle invasive bladder cancer.
- Wes Kassouf
NMIBC
Guideline
Learning objectives
As a result of attending this session, participants will be able to:
- Discuss a risk-stratified approach to treatment of NMIBC
- Identify patients who might benefit from early cystectomy
- Define current and future bladder preservation options for BCG-unresponsive NMIBC
CUASF Lecture
Surgical Blood Loss and Transfusion in Urology: A Gram of Prevention is Worth a Unit of Cure
Learning objectives
As a result of attending this session, participants will be able to:
- Learn about blood loss and transfusion in urology compared to other surgical specialties
- Review the harms of surgical blood loss and blood transfusion
- Learn methods of blood loss and transfusion prevention
Speakers
Marian Wettstein, University Health Network Toronto | Patient trajectories of a real-world cohort initiating neoadjuvant chemotherapy for localized muscle-invasive bladder cancer: A population-based study analyzed by a multi-state modelling framework |
Kashif Visram, Queen’s University | Sexual dimorphism in outcomes of non-muscle invasive bladder cancer: A role of CD163+ macrophages, B cells and PD-L1 immune checkpoint |
Amanda Hird, University of Toronto | Association between chronic urinary catheterization and bladder cancer incidence and mortality: A population-based study |
Steven Lu, University of Calgary | Assessment of the alignment between research funding allocation and consensus research priority areas in kidney cancer |
Alice Dragomir, McGill University | Role of the upfront cytoreductive nephrectomy in patients with metastatic renal cell carcinoma |
Peter Gariscsak, Queen’s University | Minimizing follow-up intensity of active surveillance for clinical stage 1 non-seminoma germ cell tumours (CS1 NSGCT): A 40-year experience at Princess Margaret Cancer Centre |
- Moderator: Luke Lavallée
Non-Prostate GU Cancers
Podium & Rapid Fire Abstracts
Learning objectives
As a result of attending this session, participants will be able to:
- Understand how to best select patients with advanced urologic cancers for therapy
- Understand how to optimize and limit the burden of follow up for patients after cancer treatment
- Understand how funding relates to prioritization of research goals in health care
Pediatrics
Vesicoureteral Reflux: Better Alone Than in Bad Company
State-of-the-Art Lecture
Learning objectives
As a result of attending this session, participants will be able to:
- Identify factors that increase adverse outcomes among vesicoureteral reflux patients
- Understand risks associated with continuous antibiotic prophylaxis usage
- Recognize the impact of adherence in vesicoureteral reflux management
- Hillary Copp, Ashley Cox, Dawn MacLellan, Hadley Wood
- Andrew MacNeily
EF5: Neurogenic bladder through their lifetime
Educational Forum
Learning objectives
As a result of attending this session, participants will be able to:
- Identify common anomalies with long-term implications
- Incidence and subsequent revisions after pediatric urologic surgery
- Identify best practice for successful transition to adult urologic follow-up
- Anil Kapoor
CUASF Grant Recipients 2021
Reconstruction
Late Effects Following Pediatric Bladder Operations for Congenital Conditions
State-of-the-Art Lecture
Learning objectives
As a result of attending this session, participants will be able to:
- Cite indications for cross sectional imaging and/or cystoscopy for patients with prior bladder reconstructions
- Describe a basic evaluation of an incontinent or obstructed continent channel (Mitrofanoff) and indications for different surgical approaches based on that evaluation
- Explain the urologists role in screening and treatment of pressure ulcers in adults with spina bifida
Speakers
Mélanie Aube-Peterkin, Urology, McGill University Health Center, Montreal | The Optilume Drug Coated Balloon for recurrent anterior urethral strictures: 3-year results for the ROBUST I study |
Jennifer Locke, Surgery, Sunnybrook Health Sciences Centre, University of Toronto | Impact of delayed recognition of Iatrogenic ureteric injury in a retrospective population-based study |
Anna Black, Urologic Sciences, University of British Columbia | Contemporary risk factors for ureteral stricture following renal transplantation |
Yilong Li, Schulich School of Medicine & Dentistry, Western University, London | Meta-analysis to study the outcomes of early versus expectant management of pediatric neurogenic bladder |
Amr Hodhod, Pediatric Urology, Alberta Children’s Hospital, Calgary | Can we improve the usefulness of the diuretic renogram in the diagnosis of UPJO? Introduction of Mercaptoacetyltriglycine-Suspected Obstruction Scoring System (MAG-SOS) |
Steven Tong, Surgery, Division of Urology, University of Alberta, Edmonton | Surgical outcomes in patients undergoing ileovesicostomy in Edmonton over the past 12 years |
- Moderator: Katherine Moore
Pediatric and Adult Reconstruction
Podium & Rapid Fire Abstracts
Learning objectives
As a result of attending this session, participants will be able to:
- Recognize challenges in the diagnosis and the management of urethral pathologies
- Enumerate challenging issues in pediatric urology practice
